✦ LIBER ✦

Thrombin inhibition protects the pulmonary xenograft from hyperacute rejection

✍ Scribed by George L. Zorn III; Steffen Pfeiffer; Agnes Azimzadeh; Richard N. Pierson III

Book ID: 114353957
Publisher: Elsevier Science
Year: 2000
Tongue: English
Weight: 195 KB
Volume: 191
Category: Article
ISSN: 1072-7515
DOI: 10.1016/s1072-7515(00)00534-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Porcine heart xenograft function and hyp

Porcine heart xenograft function and hyperacute rejection: the role of thrombin inhibition

✍ S Uchita; E Thein; H Huber; C Wimmer; F Kur; P Brenner; C Hammer 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 329 KB

Soluble complement receptor type 1 and a

Soluble complement receptor type 1 and antithrombin-III combination therapy prolongs xenograft survival: The role of thrombin and prostacyclin in hyperacute rejection

✍ I. Fujiwara; H. Nakajima; K. Akioka; T. Matsuda; T. Oka 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 335 KB

Cyclic AMP stimulation protects a porcin

Cyclic AMP stimulation protects a porcine pulmonary xenograft from hyperacute rejection: D.M. Kulick, A.P. Dalmasso, C.T. Salerno, J. Grehan, S.J. Park, M. Guzman-Paz, R.M. Bolman III, University of Minnesota, Minneapolis, MN

📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 169 KB

Non-MHC restriction in the protection fr

Non-MHC restriction in the protection from humoral rejection given by a hepatic xenograft

✍ F. Pan; L.A. Valdivia; M. Tsugita; S. Celli; A.J. Demetris; H. Sun; A.S. Rao; J. 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 87 KB

Delayed fibrin elimination from the lung

Delayed fibrin elimination from the lungs and pulmonary damage after intravenous injection of thrombin in rats with endogenous inhibition of the fibrinolytic system

✍ Tom Saldeen; Lars Bagge; Christer Busch; Lennart Rammer 📂 Article 📅 1972 🏛 Elsevier Science ⚖ 157 KB

Beta2-glycoprotein I protects thrombin f

Beta2-glycoprotein I protects thrombin from inhibition by heparin cofactor II: Potentiation of this effect in the presence of anti–β2-glycoprotein I autoantibodies

✍ Soheila Rahgozar; Bill Giannakopoulos; Xiaokai Yan; Jiewei Wei; Jian Cheng Qi; R 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 261 KB 👁 1 views

## Abstract ## Objective Beta~2~‐glycoprotein I (β~2~GPI) is an important autoantigen in the antiphospholipid syndrome (APS). In vitro studies suggest that it may have multifaceted physiologic functions, since it displays both anticoagulant and procoagulant properties. We have previously reported